oncology

See the following -

Asia’s Leading Oncology Journal Cancer Science Adopts Open Access

Press Release | Wiley, Wiley Open Access, Cancer Science, Japanese Cancer Association (JCA) | September 9, 2013

From January 1, 2014, all newly published articles will be open access and free to view, download and share. Read More »

aycan celebrates 10 years of OsiriX platform technology evolution

Press Release | aycan | March 16, 2015

aycan, a recognized global leader in medical imaging, is celebrating ten years of technology investment and innovation in the OsiriX platform, which they’ve helped evolve to now include advanced integration capabilities, a service organization, applications, and plug ins designed to improve productivity and patient care. Read More »

Big Pharma Companies Open Up Cancer Trial Comparator Arm Data

Nick Paul Taylor | Fierce Biotech IT | April 11, 2014

A lot has changed in clinical trial transparency since Project Data Sphere outlined plans to share cancer results in 2012, with the European law voted in last week then still a distant threat. Even so, Pfizer ($PFE), Sanofi ($SNY) and the other groups behind the initiative think it still offers something different now that it has belatedly launched.

Read More »

Conshohocken-Based Non-Profit Aims to Revolutionize Biopharma

T. J. Sharpe | Philly.com | December 1, 2016

What if the next big thing in biopharma wasn’t produced by one of the big pharma companies that line the Northeast corridor between Philadelphia and New York City, but by a whole bunch of them?  Conshohocken-based TransCelerate BioPharma is attempting to accomplish this difficult feat by embracing cooperation instead of competition.  It is a 501(c)3 non-profit consortium of 18 pharmaceutical companies (and growing) that works with the FDA and global regulators to advance the industry through collaboration with researchers, industry organizations, and federal oversight agencies...

Read More »

EMR Goes Global: Bringing Technology To Developing Countries

Jennifer Thew | HL7 Standards | September 18, 2012

Lately, I’ve been hearing quite a bit about global cancer care. I shouldn’t be surprised. The International Agency for Research on Cancer projects that by 2030 the incidence of all cancer cases will be 22.2 million. To learn more about the trend, I visited the Partners in Health website because they recently helped open a  new oncology hospital in Rwanda. Read More »

Expensive Drugs Forcing Cancer Doctors To Weigh Price

Robert Langreth | Bloomberg | May 31, 2014

...With new cancer drugs priced as high as $10,000 a month and more, and insurers tightening payment rules, patients who thought they were well covered increasingly find themselves having to make life-altering decisions about what they can afford. 

Read More »

IBM’s Dr. Watson Is NOT A Meaningful User

Margalit Gur-Arie | HIT Consultant | February 19, 2013

IBM’s Dr. Watson of Jeopardy! fame has finally completed its residency and fellowships and, presumably to its creators’ utter delight, is now a practicing Oncologist. The prodigy “cognitive system” completed its training in less than a year at the illustrious Memorial Sloan-Kettering Cancer Center, and although only proficient in lung cancer right now, Dr. Watson’s career as an advisor to oncologists everywhere is off to a great start... Read More »

Seven Bridges Introduces Open Source Cancer Genomics Workflow

John Otrompke | Bio IT World | August 20, 2014

Seven Bridges, a Cambridge company that builds tool to help scientists process genomic data, has created a cloud-based workflow for analyzing cancer genomes. The workflow was presented at the Biology of Genomes conference at Cold Spring Harbor in May...

Read More »

The Link Between Birth-Control Pills And Breast Cancer

Olga Khazan | The Atlantic | August 1, 2014

A new study finds that pills with a high level of estrogen increase breast-cancer risk significantly. But that still might not mean you should change your prescription...

Read More »